Amf Tjanstepension Ab Amgen Inc Transaction History

Amf Tjanstepension Ab

$13.5 Billion
Q3 2024

A detailed history of Amf Tjanstepension Ab transactions in Amgen Inc stock. As of the latest transaction made, Amf Tjanstepension Ab holds 120,389 shares of AMGN stock, worth $35.5 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

120,389

Previous 120,389 -0.0%

Holding current value

$35.5 Million

Previous $38.8 Million -0.0%

% of portfolio

0.29%

Previous 0.29%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	BUY	$309.38 - $337.38 $5.38 Million - $5.87 Million	17,387 Added 16.88%	120,389 $38.8 Million
Q2 2024 Jul 10, 2024	SELL	$262.75 - $319.31 $609,317 - $740,479	-2,319 Reduced 2.2%	103,002 $32.2 Million
Q1 2024 Apr 16, 2024	SELL	$268.87 - $324.56 $10 Million - $12.1 Million	-37,294 Reduced 26.15%	105,321 $29.9 Million
Q4 2023 Jan 30, 2024	SELL	$255.7 - $288.46 $106,882 - $120,576	-418 Reduced 0.29%	142,615 $41.1 Million
Q3 2023 Oct 26, 2023	SELL	$218.65 - $271.46 $25.1 Million - $31.1 Million	-114,587 Reduced 44.48%	143,033 $38.4 Million
Q2 2023 Jul 05, 2023	SELL	$214.27 - $253.37 $8.13 Million - $9.61 Million	-37,935 Reduced 12.84%	257,620 $57.2 Million
Q1 2023 Apr 24, 2023	SELL	$225.79 - $275.2 $4.12 Million - $5.03 Million	-18,265 Reduced 5.82%	295,555 $71.5 Million
Q4 2022 Jan 26, 2023	BUY	$229.03 - $291.01 $951,619 - $1.21 Million	4,155 Added 1.34%	313,820 $0
Q3 2022 Oct 26, 2022	SELL	$224.46 - $253.15 $350,830 - $395,673	-1,563 Reduced 0.5%	309,665 $69.9 Million
Q2 2022 Jul 26, 2022	SELL	$230.71 - $256.74 $15.8 Million - $17.5 Million	-68,356 Reduced 18.01%	311,228 $75.8 Million
Q1 2022 May 05, 2022	BUY	$219.27 - $242.57 $2.45 Million - $2.71 Million	11,192 Added 3.04%	379,584 $91.9 Million
Q4 2021 Feb 08, 2022	BUY	$198.88 - $227.6 $5.08 Million - $5.81 Million	25,529 Added 7.45%	368,392 $82.9 Million
Q3 2021 Nov 03, 2021	BUY	$212.27 - $248.7 $8.34 Million - $9.77 Million	39,304 Added 12.95%	342,863 $73 Million
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $8.42 Million - $9.35 Million	-36,062 Reduced 10.62%	303,559 $74.1 Million
Q4 2020 Feb 02, 2021	SELL	$216.38 - $257.67 $10.9 Million - $13 Million	-50,397 Reduced 12.92%	339,621 $78.2 Million
Q3 2020 Nov 09, 2020	BUY	$234.65 - $260.95 $4.08 Million - $4.53 Million	17,367 Added 4.66%	390,018 $99.1 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $8.42 Million - $10.3 Million	-42,546 Reduced 10.25%	372,651 $87.9 Million
Q1 2020 Apr 14, 2020	SELL	$182.24 - $241.7 $12.8 Million - $17 Million	-70,207 Reduced 14.46%	415,197 $84.2 Million
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $250,703 - $322,240	-1,325 Reduced 0.27%	485,404 $117 Million
Q3 2019 Oct 29, 2019	SELL	$174.11 - $208.62 $6.6 Million - $7.91 Million	-37,920 Reduced 7.23%	486,729 $94.2 Million
Q2 2019 Jul 11, 2019	BUY	$166.7 - $195.41 $13.9 Million - $16.3 Million	83,441 Added 18.91%	524,649 $96.7 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $14.8 Million - $16.7 Million	-81,749 Reduced 15.63%	441,208 $83.8 Million
Q4 2018 Jan 30, 2019	SELL	$178.4 - $208.25 $18 Million - $21 Million	-100,984 Reduced 16.18%	522,957 $102 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $1.14 Million - $1.29 Million	-6,158 Reduced 0.98%	623,941 $129 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $7.38 Million - $8.29 Million	-44,440 Reduced 6.59%	630,099 $116 Million
Q1 2018 May 10, 2018	BUY	$169.43 - $198.0 $6.28 Million - $7.33 Million	37,039 Added 5.81%	674,539 $115 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $5.1 Million - $5.7 Million	30,237 Added 4.98%	637,500 $111 Million
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $102 Million - $116 Million	607,263	607,263 $113 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amf Tjanstepension Ab, based on Form 13F filings with the SEC.

News

Stay updated on Amf Tjanstepension Ab with notifications on news.

Account

Amf Tjanstepension Ab Amgen Inc Transaction History